Health and Wellness

Impeto’s SUDOSCAN technology for monitoring peripheral neuropathies is included in Withings’ recently announced Body Scan smart scale.

The company plans to use the funding to expand its commercial team, scale operations and develop new products.

The growth of telehealth and remote-monitoring tools could be a game-changer for women's health, particularly maternal and fetal care.

During a panel at CES, leaders at digital therapeutic companies discuss the state of the market right now and what’s needed to boost adoption.

Also: Medicare Advantage insurer Zing Health partners with Papa. Verily and biopharma-company Sosei Heptares announce a research collaboration. Pharma-focused accelerator PharmStars’ next cohort will focus on neurological diseases.

The company plans to expand its services nationwide by 2023. 

Also: Ghanian startup mPharma raises $35 million, and child RPM maker Kiddo scoops up $16 million.

Babylon became a strategic investor in Higi, the maker of health-checking kiosks found in groceries and pharmacies, in May 2020.

Investment will help the company raise awareness of its product in Europe, the Middle East and Asia.

The company said the smart scale will be available in the latter half of 2022 following regulatory clearance.